You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -132.5% | -122.3% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -5.9 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 6.3 | 4.4 |
| Price / Book value | 1.2 |
| Latest | Forecast | |
|---|---|---|
| Revenue | -6.4% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 26.00 | -11.82 | $-0.17 | -42.4 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 33.89 | -19.08 | $-0.21 | -48.6 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | 44.26 | -23.57 | $-0.55 | -9.6 | 0.0 | n/a | n/a | 0.0% |
| 2023-12-31 | 41.29 | -37.92 | $-0.37 | -12.1 | 0.0 | n/a | n/a | 0.0% |
| 2024-12-31 | 38.63 | -41.06 | $-0.39 | -10.4 | 0.0 | n/a | n/a | 0.0% |
| MaxCyte signs SPL deal with TG Therapeutics Sharecast News | 12 Feb |
|---|---|
| MaxCyte announces acquisition of SeQure Dx Sharecast News | 30 Jan |
| MaxCyte flags full-year revenue at top end of expectations Sharecast News | 13 Jan |
| Filing of Form 10-Q | 09-May-25 07:01 |
|---|---|
| First Quarter 2025 Financial Results | 08-May-25 07:02 |
| Total Voting Rights | 02-May-25 22:56 |
| Filing of definitive proxy statement | 28-Apr-25 23:05 |
| Holding(s) in Company | 22-Apr-25 14:44 |